Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. NBP176335E

Novus Biologicals™ klra3 Antibody Blocking Peptide
SDP

Catalog No. NBP176335E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP176335E 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP176335E Supplier Novus Biologicals™ Supplier No. NBP176335PEP
Add to Cart
Add to Cart

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide from 14 amino acids near the center of mouse KLRA3. Source: Synthetic (Accession #: AAI32525) The klra3 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 16634
Species Mouse
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-76335. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias 5E6, Klra3 killer cell lectin-like receptor, subfamily A, member 3, Ly49c, Nk2, Nk-2, Nk2.1, NK-2.1
Gene Symbol KLRA3
Product Type klra3
Quantity 0.05 mg
Regulatory Status RUO - research use only
Source Synthetic
Termination 14 amino acids near the center of mouse KLRA3
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.